ERS/EBMT guideline recommendations on pulmonary cGvHD

After an allogeneic stem cell transplant (alloHCST), life-threatening chronic graft-versus-host disease (cGvHD) occurs again and again. This is when the donor’s immune cells attack the recipient’s body. Lung involvement in particular is a potentially life-threatening disease and the quality of life is often significantly impaired. In order to provide a remedy, the European Respiratory Society (ERS) and the European Society for Blood and Marrow Transplantation (EBMT) published international guidelines for the treatment of pulmonary cGvHD last year.